Prokidney (PROK) Shares Outstanding (Diluted Average) (2021 - 2026)

Prokidney (PROK) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $141.9 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $141.9 million, up 11.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $141.9 million (up 11.77% YoY), and the FY2025 annual result was $133.9 million, up 36.79% from the prior year.
• Shares Outstanding (Diluted Average) grew to $141.9 million in Q1 2026 per PROK's latest filing, from $133.9 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $141.9 million in Q1 2026 and troughed at $25.6 million in Q2 2022.
• A 5-year average of $86.8 million and a median of $70.2 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Diluted Average) soared 366.18% in 2022, then dropped 0.96% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $61.5 million in 2022, then advanced by 0.28% to $61.7 million in 2023, then surged by 58.66% to $97.9 million in 2024, then surged by 36.79% to $133.9 million in 2025, then increased by 5.96% to $141.9 million in 2026.
• Business Quant data shows PROK's Shares Outstanding (Diluted Average) at $141.9 million in Q1 2026, $133.9 million in Q4 2025, and $135.0 million in Q3 2025.